Advertisement
Organisation › Details
PSIM Fund (managed by Bpifrance)
Bpifrance is the French national investment bank: it finances businesses – at every stage of their development – through loans, guarantees, equity investments and export insurances. Bpifrance also provides extra financial services (training, consultancy) to help entrepreneurs meet their challenges (innovation, export…). Created in June 2017 as part of the Future Investment Program (PIA) and managed on behalf of the State by Bpifrance, the PSIM fund "Major Innovation Support Program" aims in particular to support the winners of the Global Innovation Competition via an equity investment. It enables French start-ups to move towards the industrialization of their breakthrough innovations and their international development. *
Start | 2017-06-01 established | |
Group | France (govt) | |
Industry | finance | |
Industry 2 | business development (state/region) | |
Region | France_oo | |
Country | France | |
City | n. a. | |
Address record changed: 2018-01-20 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Depixus S.A.S.. (12/15/21). "Press Release: Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing". Paris & Cambridge. | ||
Record changed: 2024-02-12 |
Advertisement
More documents for France (govt)
- [1] Global Bioenergies S.A.. (10/4/23). "Press Release: French Government Awards Global Bioenergies €16.4 Million to Help Fund Construction of the World’s First Biosourced Isobutene Plant". Évry....
- [2] EverImmune. (9/19/23). "Press Release: EverImmune Secures €3.5 Million in Financing from Bpifrance". Villejuif....
- [3] Biper Therapeutics S.A.S.. (2/14/23). "Press Release: Biper Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-Class Small Molecules to Treat Gastrointestinal Cancers". Strasbourg....
- [4] Theranexus S.A.. (10/20/22). "Press Release: Theranexus and Inserm Transfert Sign a Strategic Alliance to Identify Advanced Therapy Drug Candidates for Rare Neurological Diseases". Lyon....
- [5] AdBio Partners S.A.S.. (5/3/22). "Press Release: AdBio Partners Welcomes Inserm Transfert as Investor in Second Fund – AFB Fund II". Paris....
- [6] Hemerion Therapeutics S.A.S.. (4/14/22). "Press Release: Hemerion Therapeutics successfully raises over €3.5 million: a new hope for the treatment of brain cancer". Villeneuve d’Ascq....
- [7] SeaBeLife S.A.S.. (3/14/22). "Press Release: SeaBeLife Receives Close to €1.4M Deep Tech Financing from Bpifrance". Roscoff....
- [8] Cell-Easy. (2/28/22). "Press Release: The OPTI-STEM Consortium Led by CDMO Cell-Easy Receives €7M from the French Government and Bpifrance and €800,000 from the Occitanie Region to Democratize Access to Cell Therapy in France and Europe". Toulouse, La...
- [9] Amolyt Pharma S.A.S.. (2/4/22). "Press Release: Amolyt Pharma Selected for the French Tech 120 Program". Lyon & Cambridge, MA....
- [10] Signia Therapeutics S.A.S.. (1/5/22). "Press Release: Signia Therapeutics Receives a €1.7 Million Deeptech Development Grant from Bpifrance". Lyon....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top